Meike Dittmann

About Meike Dittmann

Infectious disease R&D leader with expertise translating viral, bacterial, and fungal biology and host-pathogen mechanisms into therapeutic strategies. Associate Director at Regeneron Pharmaceuticals, leading multidisciplinary teams advancing biologics discovery and development programs from early concept through IND-enabling stages. Former NIH-funded investigator and laboratory head at NYU Grossman School of Medicine with a track record of defining research strategy, allocating resources, evaluating external scientific opportunities, and delivering high-impact collaborative programs. Recognized for scientific contributions in host-pathogen biology and for leading cross-functional, cross-sector collaborations.CORE SKILLS- Infectious Disease & Anti-Infective R&D: Viral, bacterial, and fungal pathogenesis | Resistance and host-pathogen interactions | Target identification, validation, and mechanistic studies- Drug Discovery & Translational Science: Biologics, antibodies & host-directed therapies | Preclinical program design and go/no-go decisions | Proof-of-concept evaluation- Leadership & Program Management: Multidisciplinary team leadership | Milestone-driven program execution | Senior leadership presentations on programs and strategy- Scientific Impact & Recognition: NIH-funded investigator and award recipient | Editorial leadership and grant review experience | Internationally recognized for antiviral innate immunity and host-pathogen biology

Experience

1. Associate Professor

   NYU Langone Health

   Mar 2023 — Present · New York, NY, US

   Directed an extramurally funded infectious disease research program spanning interferons and innate immune responses, viral and bacterial pathogenesis, antiviral therapeutics, and collaborative viral-bacterial co-infection research- Managed a $5M research budget and project portfolio over 8 years, setting priorities, allocating resources, and directing research strategy to sustain a high-performing infectious disease program- Contributed to high-profile, global consortium efforts within the SARS-CoV-2 Assessment of Viral Evolution program, coordinated across academia, industry, and government partners to evaluate viral evolution and therapeutic resilience- Evaluated and influenced external funding decisions through service on peer review groups and study sections shaping infectious disease research portfolios (DoD PRMRP; UK MRC DPFS; NIH/NIAID ZRG1; NIH/NIAID Viral Dynamics & Transmission)- Secured funding from NIH (R00, R01, R21, T32, CEIRR) and The Mathers Charitable Foundation to enable ongoing research studies- Mentored 31 direct trainees (4 postdocs, 7 graduate students, 9 rotation students, 5 research assistants, and 6 undergraduate/summer researchers), additional graduate students through thesis committees, and junior faculty through external advising and faculty mentoring programs- Presented research at institutional seminars, as an invited speaker at external institutions (e.g, UPenn, UCSF, Columbia University, U of Heidelberg), and at national and international conferences (e.g, AAI, ASV, Cytokines)- Led institutional BSL-3 COVID-19 research in rapid pandemic response, including viral stock sourcing, biosafety approvals (local, state, federal), SOP development, experimental design support, grant writing support, personnel training, and in vitro and in vivo study execution- Executed CRO studies to advance COVID-19 therapeutics into the clinic; rapidly operational by April 2020 and strategically prioritized high-probability programs.

Education

• University of Tübingen

  Bachelor of Laws (LL.B.), Administrative Law

  1999 — 2001

• University of Ulm

  Doctor of Philosophy (Ph.D.), Virology

  2006 — 2009

• University of Tübingen

  Diploma, Microbiology (Major)

  2001 — 2006

• The Rockefeller University

  Postdoctoral, Virology

  2011 — 2016

Skills

• Fluorescence Spectroscopy
• Molecular Biology
• Fluorescence Microscopy
• Cell Biology
• Laboratory
• Laboratory Skills
• Pcr
• Biochemistry
• Infectious Diseases
• Molecular Cloning
• Virology
• Screening
• Western Blotting
• Molecular Diagnostics
• University Teaching
• Tissue Culture
• Assay Development
• Cell Culture
• High Throughput Screening
• Microbiology
• Polymerase Chain Reaction (Pcr)
• Grant Writing
• Cell Based Assays
• Cell
• Administrative Law
• Virus Culture
• Life Sciences
• Luciferase Assay
• High-Throughput Screening